Drugs / bivalent OPV
bivalent OPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02477046 | Apr 2015 → Jul 2016 | — | University of Virginia | Unknown | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent OPV | “bivalent OPV (bOPV) plus inactivated polio vaccine (IPV)” NCT02477046 ↗ |
| Known as | bivalent types 1 and 3 oral polio vaccine | “bivalent types 1 and 3 oral polio vaccine (bOPV)” PMID 28693854 ↗ Jul 2017 |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02477046 ↗ |
| Modality | Vaccine | “bivalent types 1 and 3 oral polio vaccine (bOPV)” PMID 28693854 ↗ Jul 2017 |
| Route | Oral | “bivalent types 1 and 3 oral polio vaccine (bOPV)” PMID 28693854 ↗ Jul 2017 |